Thomas J. Schall

Insider Reports History

Entity
Individual
Location
850 Maude Avenue, Mountain View, CA
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas J. Schall:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immuneering Corp Director Class A Common Stock 2.9K $7.39K $2.55 Mar 22, 2024 Direct
Immuneering Corp Director Stock Option 8.59K Jun 12, 2024 Direct
ChemoCentryx, Inc. President and CEO, Director Common Stock 0 $50.95 Oct 20, 2022 Direct
ChemoCentryx, Inc. President and CEO, Director Restricted Stock Unit 0 Oct 20, 2022 Direct
ChemoCentryx, Inc. President and CEO, Director Stock Option 0 Oct 20, 2022 Direct

Insider Reports Filed by Thomas J. Schall

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMRX Immuneering Corp Jun 12, 2024 1 $0 4 Jun 13, 2024 Director
IMRX Immuneering Corp Mar 22, 2024 1 $7.38K 4 Mar 25, 2024 Director
IMRX Immuneering Corp Mar 11, 2024 1 $0 4 Mar 12, 2024 Director
IMRX Immuneering Corp Mar 11, 2024 0 $0 3 Mar 12, 2024 Director
CCXI ChemoCentryx, Inc. Oct 20, 2022 20 $0 4 Oct 24, 2022 President and CEO, Director
CCXI ChemoCentryx, Inc. Aug 4, 2022 3 -$4.68M 4 Aug 8, 2022 President and CEO, Director
CCXI ChemoCentryx, Inc. Feb 22, 2022 2 $0 4 Feb 25, 2022 President and CEO, Director
CCXI ChemoCentryx, Inc. Jan 1, 2022 7 -$1.66M 4 Jan 4, 2022 President and CEO, Director
CCXI ChemoCentryx, Inc. Dec 1, 2021 4 $500K 4 Dec 3, 2021 President and CEO, Director